DIA 48th Annual Meeting
Click here to go to the previous page
Clinical Outcome Assessments in the Evaluation of Medical Products in Pediatrics
Track
:
Track 07: Processes and Technologies for Clinical Research
Program Code:
335
Date:
Wednesday, June 27, 2012
Time:
10:00 AM to 11:30 AM
EST
CHAIR
:
Elektra Papadopoulos, FDA, United States
PRESENTER
(S):
Carla Epps, FDA, United States
Donald Patrick, University of Washington, United States
Description
This session will discuss considerations for selection and/or development of well defined and reliable pediatric clinical outcome assessment tools.
Learning Objectives:
Discuss the important considerations for selecting well-defined and reliable clinical outcome assessment tools for use in pediatric populations
Discuss planning for pediatric clinical outcome assessment in drug development.
Learning Objectives:
Discuss the important considerations for selecting well-defined and reliable clinical outcome assessment tools for use in pediatric populations
Discuss planning for pediatric clinical outcome assessment in drug development.
This session is a part of:
Handout Online
